The PRISMA statement extension for systematic reviews incorporating network meta-analysis: PRISMA-NMA;La extensión de la declaración PRISMA para revisiones sistemáticas que incorporan metaanálisis en red: PRISMA-NMA

Medicina Clinica

Volumn 147, Issue 6, 2016, Pages 262-266

  Hutton, Brian ^a,b   Catalá López, Ferrán ^a,c,d   Moher, David ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c Fundacion Instituto de Investigacion en Servicios de Salud   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; META ANALYSIS (TOPIC); SYSTEMATIC REVIEW (TOPIC); CHECKLIST; LITERATURE; METHODOLOGY; NETWORK META-ANALYSIS; PUBLICATION; PUBLISHING; STANDARDS;

CHECKLIST; NETWORK META-ANALYSIS; PUBLISHING; RESEARCH DESIGN; REVIEW LITERATURE AS TOPIC; TRANSLATIONS;

EID: 84961903996     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2016.02.025     Document Type: Article

References (21)

1. 1 Moher, D., Tetzlaff, J., Tricco, A.C., Sampson, M., Altman, D.G., Epidemiology and reporting characteristics of systematic reviews. PLoS Med., 4, 2007, e78.
2. 2 Moher, D., Cook, D.J., Eastwood, S., Olkin, I., Rennie, D., Stroup, D.F., Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 354 (1999), 1896–1900.
3. 3 Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med 151 (2009), 264–269.
4. 4 Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gøtzsche, P.C., Ioannidis, J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med., 6, 2009, e1000100.
5. 5 Urrútia, G., Bonfill, X., Declaración PRISMA: una propuesta para mejorar la publicación de revisiones sistemáticas y metaanálisis. Med Clin (Barc). 135 (2010), 507–511.
6. 6 Panic, N., Leoncini, E., de Belvis, G., Ricciardi, W., Boccia, S., Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses. PLoS One., 8, 2013, e83138.
7. 7 Mills, E.J., Ioannidis, J.P., Thorlund, K., Schünemann, H.J., Puhan, M.A., Guyatt, G.H., How to use an article reporting a multiple treatment comparison meta-analysis. JAMA. 308 (2012), 1246–1253.
8. 8 Catalá-López, F., Tobías, A., Síntesis de la evidencia clínica y metaanálisis en red con comparaciones indirectas. Med Clin (Barc). 140 (2013), 182–187.
9. 9 Hutton, B., Salanti, G., Chaimani, A., Caldwell, D.M., Schmid, C., Thorlund, K., et al. The quality of reporting methods and results in network meta-analyses: An overview of reviews and suggestions for improvement. PLoS One., 9, 2014, e92508.
10. 10 Bafeta, A., Trinquart, L., Seror, R., Ravaud, P., Reporting of results from network meta-analyses: Methodological systematic review. BMJ., 348, 2014, g1741.
11. 11 Bafeta, A., Trinquart, L., Seror, R., Ravaud, P., Analysis of the systematic reviews process in reports of network meta-analyses: Methodological systematic review. BMJ., 347, 2013, f3675.
12. 12 Hutton, B., Salanti, G., Caldwell, D.M., Chaimani, A., Schmid, C.H., Cameron, C., et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations. Ann Intern Med. 162 (2015), 777–784.
13. 13 Altman, D.G., Moher, D., [Developing guidelines for reporting healthcare research: scientific rationale and procedures] Spanish. Med Clin (Barc). 125:Suppl 1 (2005), 8–13.
14. 14 Moher, D., Schulz, K.F., Simera, I., Altman, D.G., Guidance for developers of health research reporting guidelines. PLoS Med., 7, 2010, e1000217.
15. 15 Catalá-López, F., Tobías, A., Roqué, M., Conceptos básicos del metaanálisis en red. Aten Primaria. 46 (2014), 573–581.
16. 16 PRISMA-Statement website. PRISMA translations policy [consultado 22 Oct 2015]. Disponible en: http://www.prisma-statement.org/Translations/TranslationsPolicy.aspx.
17. 17 Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation. BMJ., 349, 2015, g7647.
18. 18 Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev., 4, 2015, 1.
19. 19 Beller, E.M., Glasziou, P.P., Altman, D.G., Hopewell, S., Bastian, H., Chalmers, I., et al. PRISMA for abstracts: Reporting systematic reviews in journal and conference abstracts. PLoS Med., 10, 2013, e1001419.
20. 20 Welch, V., Petticrew, M., Tugwell, P., Moher, D., O'Neill, J., Waters, E., et al. PRISMA-Equity 2012 extension: Reporting guidelines for systematic reviews with a focus on health equity. PLoS Med., 9, 2012, e1001333.
21. 21 Stewart, L.A., Clarke, M., Rovers, M., Riley, R.D., Simmonds, M., Stewart, G., et al. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: The PRISMA-IPD Statement. JAMA. 313 (2015), 1657–1665.